Developing a new vaccine to improve flu protection in older adults
Combination nanovaccine-based immunization against influenza virus in the aged: immunity and protection
This study is testing a new type of vaccine to help older adults, especially those 65 and up, have a stronger immune response against the flu, making it more effective for them.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Iowa State University NIH-funded |
| Lab location | 1 site (Ames, United States) |
| Project ID | NIH-11012289 on NIH RePORTER |
What this research studies
This research focuses on creating a nanovaccine specifically designed to enhance the immune response against the influenza virus in individuals aged 65 and older. It aims to address the age-related decline in vaccine effectiveness by investigating how different vaccine materials and adjuvants can improve immune cell function. The study will explore the mechanisms that allow these new vaccine formulations to boost both antibody production and T cell memory, ultimately leading to better protection against influenza. By optimizing these vaccine components, the research seeks to provide a more effective immunization strategy for older adults.
Who could benefit from this research
Good fit: Ideal candidates for this research are adults aged 65 and older who are at higher risk for complications from influenza.
Not a fit: Patients under the age of 65 or those with specific contraindications to vaccination may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to a more effective influenza vaccine that significantly reduces hospitalizations and deaths among older adults.
How similar studies have performed: Previous research has shown promise in using novel vaccine platforms to enhance immune responses in older populations, indicating potential for success in this approach.
Where this research is happening
Ames, United States
- Iowa State University — Ames, United States (Active)
Researchers
- Principal investigator: Kohut, Marian L — Iowa State University
- Study coordinator: Kohut, Marian L
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.